Judge Tosses $140M Verdict Against AbbVie Over Testosterone Drug
A U.S. judge on Thursday overturned a $140.1 million verdict against AbbVie Inc. in a lawsuit by a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack. U.S. …